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Lee et al. present evidence establishing
that Presenilin 1 loss of function elevates
lysosomal pH via loss of V0a1 vATPase
subunits. Besides disrupting autophagy,
elevated lysosomal pH hyperactivates the
TRPML1 calcium channel, causing
increased lysosomal calcium efflux and
cytosolic calcium elevation, thus linking
two AD-related presenilin phenotypes to
vATPase deficiency.
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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARY
Presenilin 1 (PS1) deletion or Alzheimer’s disease
(AD)-linkedmutations disrupt lysosomal acidification
and proteolysis, which inhibits autophagy. Here, we
establish that this phenotype stems from impaired
glycosylation and instability of vATPase V0a1 sub-
unit, causing deficient lysosomal vATPase assembly
and function. We further demonstrate that elevated
lysosomal pH in Presenilin 1 knockout (PS1KO) cells
induces abnormal Ca2+ efflux from lysosomes medi-
ated by TRPML1 and elevates cytosolic Ca2+. In WT
cells, blocking vATPase activity or knockdown of
either PS1 or the V0a1 subunit of vATPase repro-
duces all of these abnormalities. Normalizing lyso-
somal pH in PS1KO cells using acidic nanoparticles
restores normal lysosomal proteolysis, autophagy,
and Ca2+ homeostasis, but correcting lysosomal
Ca2+ deficits alone neither re-acidifies lysosomes
nor reverses proteolytic and autophagic deficits.
Our results indicate that vATPase deficiency in PS1
loss-of-function states causes lysosomal/autophagy
deficits and contributes to abnormal cellular Ca2+ ho-
meostasis, thus linking two AD-related pathogenic
processes througha commonmolecularmechanism.INTRODUCTION
Presenilin 1 (PS1) is primarily known to be a catalytic component
of g-secretase complex, which carries out cleavage of amyloid
precursor protein yielding Abeta peptides, which in various1430 Cell Reports 12, 1430–1444, September 1, 2015 ª2015 The Auforms have been implicated in AD pathogenesis (Cha´vez-Gutie´r-
rez et al., 2012; De Strooper and Annaert, 2010; Selkoe and
Wolfe, 2007; Steiner and Haass, 2000). Loss-of-function muta-
tions of PS1 that cause early-onset Alzheimer’s disease (AD)
alter the proportion of Abeta 42 and 40 peptides (Cha´vez-Gutie´r-
rez et al., 2012), which is considered critical to their neurotoxicity
and a major contributor to AD pathogenesis. Increasing evi-
dence, however, indicates that PS1 serves additional g-secre-
tase-independent roles in wnt signaling (Kang et al., 1999), endo-
plastmic reticulum (ER) Ca2+ regulation (Shilling et al., 2014; Tu
et al., 2006), as well as lysosomal function and autophagy
(Coen et al., 2012; Lee et al., 2010; Wilson et al., 2004; Wolfe
et al., 2013). PS1 dysfunction is therefore likely to contribute in
multiple ways to AD pathogenesis by altering Abeta clearance,
production, and oligomerization (Nixon, 2007) and corrupting
diverse lysosomal functions via the massive buildup of incom-
pletely degraded autophagic substrates in lysosomes, a charac-
teristic feature of the neuritic dystrophy in AD (Nixon and Yang,
2012). Lysosomal dysfunction in neurons is closely tied to neuro-
degeneration and cell death mechanisms (Cesen et al., 2012;
Nixon and Yang, 2012). Growing genetic and biochemical evi-
dence implicates dysfunction of the endosomal-lysosomal and
autophagic lysosomal pathways in the pathogenesis of a num-
ber of neurodegenerative disorders, including AD, Parkinson’s
disease, and amyotrophic lateral sclerosis (ALS) (Frakes et al.,
2014; Ghavami et al., 2014; Menzies et al., 2015; Nixon, 2013).
The therapeutic efficacy of autophagy/lysosome modulation in
animal models of these disorders (Butler et al., 2011; Sun
et al., 2008; Yang et al., 2011) further underscores the signifi-
cance of lysosomal impairments to disease pathogenesis.
It has been shown that loss of PS1 function in multiple cell
types disrupts lysosome acidification, leading to markedly im-
paired autophagy (Avrahami et al., 2013; Dobrowolski et al.,
2012; Lee et al., 2010; Torres et al., 2012; Wolfe et al., 2013).thors
Controversial reports from two groups (Coen et al., 2012; Zhang
et al., 2012a), however, proposed that PS1 plays no role in lyso-
somal pH, lysosomal proteolysis, or vATPase subunit maturation
and that the V0a1 subunit specifically implicated in our studies is
not involved in lysosomal acidification.
Here, we directly demonstrate deficiencies in lysosomal
vATPase content and function in lysosomes of Presenilin 1
knockout (PS1KO) cells and establish the role of failed vATPase
V0a1 subunit maturation in PS1-dependent lysosomal acidifi-
cation failure, leading to defective autophagy and abnormal
efflux of lysosomal Ca2+. We further show that the secondary
abnormalities in lysosomal Ca2+ efflux are caused by a pH-
modulated activation of the low H+-sensitive endolysosomal
Ca2+ channel, transient receptor potential cation channel mu-
colipin subfamily member 1 (TRPML1) (Raychowdhury et al.,
2004), and are responsible for substantial elevations of cyto-
solic Ca2+ in PS1-deficient cells. We present further evidence
that the V0a1 subunit is essential for lysosome acidification in
neurons and non-neural cells and that inhibiting vATPase func-
tion in WT cells recapitulates the PS1KO phenotype. Restoring
normal lysosomal pH using lysosome-targeted acidic nanopar-
ticles reverses these abnormalities, but the correction of lyso-
somal Ca2+ deficits alone does not, thus implying that lyso-
somal pH modulates TRPML1 activation and Ca2+ efflux as a
secondary consequence of vATPase deficiency in PS1KO cells.
Our studies, therefore, link two g-secretase-independent ef-
fects of PS1, each having pathogenic significance in AD, and
demonstrate that vATPase deficiency is a common underlying
mechanism.
RESULTS
PS1-Dependent Regulation of Lysosomal pH Is Essential
for Lysosomal Ca2+ Homeostasis Mediated by TRPML1
To investigate the relationship between defects in lysosomal
Ca2+ homeostasis and lysosomal acidification in PS1KO cells,
we measured lysosomal Ca2+ levels and observed lowered lyso-
somal Ca2+ levels, as previously reported (Coen et al., 2012) and
concomitantly elevated cytosolic Ca2+ levels (Figure 1A). We
confirmed lysosomal Ca2+ reduction by assaying Ca2+ release
after pretreatment with ionomycin to release all internal, non-
lysosomal calcium stores (Lloyd-Evans et al., 2008), followed
by glycyl-L-phenylalanine-beta-naphthylamide (GPN) to induce
lysosomal rupture causing the release of lysosomal Ca2+ (Penny
et al., 2014). Interestingly, GPN elevated cytosolic Ca2+ due to
lysosomal Ca2+ release after ionomycin treatment in WT, but
had minimal effect on PS1KO cells (Figure 1B). To confirm in
PS1KO cells that reduced lysosomal Ca2+ release after GPN is
due to deficient lysosomal calcium stores, we treated WT cells
with U18666a, a control agent used to deplete lysosomal Ca2+
stores without affecting vATPase function (Lloyd-Evans et al.,
2008). As expected, U18666A-treated WT cells exhibited a
marked reduction in the rise of cytosolic Ca2+ due to lysosomal
Ca2+ release following addition of ionomycin and then GPN.
Importantly, the magnitude of the reduction of lysosomal Ca2+
release was similar to that observed in untreated PS1KO cells
(Figure 1B), again showing that levels of lysosomal Ca2+ are
markedly lowered in PS1KO cells.Cell ReLysosomal Ca2+ channels, including TPC1/2, are NAADP
dependent and sensitive to lysosomal pH. At normal lysosomal
pH, elevated cytosolic NAADP transiently binds the channel, trig-
gering lysosomal Ca2+ release, but at elevated lysosomal pH,
TPC2 channels are blocked because NAADP cannot dissociate
to re-trigger additional Ca2+ release (Pitt et al., 2010). We inves-
tigated the effects of NAADP-AM after clamping the ER store
with thapsigargin. Untreated WT cells showed an increase in
cytosolic Ca2+ after NAADP-AM addition (Figure 1C), and pre-
treatment with U18666A reduced the rise in cytosolic Ca2+, re-
flecting the loss of Ca2+ from the lysosome (Figures 1B and
1C). By contrast, PS1KO cells showed no NAADP-dependent
Ca2+ release (Figure 1C) despite the presence of a remaining,
albeit diminished, lysosomal Ca2+ pool (Figures 1A and 1B).
Given that elevated lysosomal pH blocks TPC channels, the
lack of response to NAADP-AM in PS1KO cells provided further
evidence for a lysosomal pH defect and implied a different cause
for Ca2+ leak. Because of a lack of NAADP-mediated lysosomal
Ca2+ release in PS1KO cells, we investigated the cause of the
reduced lysosomal Ca2+ levels by focusing on another endolyso-
somal Ca2+ permeant channel reported to be activated in its
endogenous state by elevated lysosomal pH, namely TRPML1
(Raychowdhury et al., 2004).
To analyze the lysosomal pH dependence of TRPML1 activity
in PS1KO cells, we first altered lysosomal proton content with
NH4+, which alkalinizes the lysosome only at high concentra-
tions, thereby inducing Ca2+ leak and emptying lysosomal
Ca2+ stores (Christensen et al., 2002). We hypothesized that a
weak lysosomal alkalinization stimulus (5 mM, <2 min), which
does not affect lysosomal pH inWT cells (data not shown), would
trigger Ca2+ leak more readily in the elevated lysosomal pH in
PS1KO cells. As expected, this condition triggered a significant
Ca2+ leak from PS1KO compared to WT cells (Figure 1D). These
data indicated that PS1KO cells more readily leak Ca2+ with the
addition of small amounts of an alkalinizing agent and suggested
that other pH sensitive channels, like TRPML1, might become
hyperactive at elevated pH. To investigate this hypothesis, we
treated cells with the TRPML1 agonist ML-SA1 (Grimm et al.,
2010). Although a low dose (20 mM) of ML-SA1 induced only a
minimal elevation in cytosolic Ca2+ in WT cells (Figure 1E), cyto-
solic Ca2+ rose markedly in PS1KO cells (Figure 1E).
While TPC2 and TRPML1 are functionally distinct (Yamaguchi
et al., 2011), they are both activated by phosphoinositols (Dong
et al., 2010; Jha et al., 2014), suggesting that they could both be
inhibited by similar ligands. Ned-19, an NAADP analog, inhibits
activation of NAADP-dependent lysosomal Ca2+ channels pre-
venting Ca2+ efflux (Naylor et al., 2009). Surprisingly, Ned-19 pre-
treatment of PS1KO cells inhibited TRPML1, and cytosolic Ca2+
elevation induced by ML-SA1 was now corrected back to WT
levels in the Ned-19-treated PS1KO cells (Figure 1E).
Given that Ned-19 has been previously known to inhibit only
lysosomal NAADP-dependent Ca2+ channels, we investigated
the possibility that Ned-19 inhibits channels in addition to TPC2
by knocking down TPC2 in PS1KO cells. Knockdown of TPC2
had no effect on either lysosomal or cytosolic Ca2+ levels (Figures
1F and S1A), confirming that it is inactive at the abnormally high
lysosomal pH. However, consistent with the idea that Ned-19
can target other lysosomal Ca2+ channels, Ned-19 increasedports 12, 1430–1444, September 1, 2015 ª2015 The Authors 1431
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lysosomal Ca2+ and decreased cytosolic Ca2+ in both PS1KO
and shTPC2 PS1KO cells (Figure 1F). To verify that TRPML1 is
the primary Ca2+ efflux channel in PS1KO cells, we knocked
down TRPML1 in PS1KO cells, which restored both lysosomal
and cytosolic Ca2+ to nearWT levels (Figures 1G andS1A).More-
over, an anti-TRPML1 antibody that inhibited the activation of
the channel (Zhang et al., 2009) efficiently inhibited the rise in
cytosolic Ca2+ induced by ML-SA1 (Figure 1H). As additional
confirmation, we treated PS1KO cells with YM201636 to inhibit
the synthesis of PI(3,5)P2, the endogenous potentiator of
TRPML1 channel opening (Zhang et al., 2012b), which reduced
the opening frequency of TRPML1. After GPN-induced rupture
of lysosomal membranes, cytosolic Ca2+ rose in PS1KO cells to
levels nearly equal to those of WT cells, indicating an increase
in the releasable pool of lysosomal Ca2+ (Figure 1I).
We confirmed that TRPML1 is responsible for depleting lyso-
somal Ca2+ at the elevated pH in PS1KO cells by demonstrating
that concanamycin A (ConA) inhibition of vATPase activity in
control human fibroblasts induced a PS1KO-like elevation of
lysosomal Ca2+ release in response to the TRPML1 agonist
ML-SA1, whereas MLIV human fibroblasts, containing inactive
TRPML1, showed no response (Figure 1J), indicating an eleva-
tion of lysosomal pH can induce hyperactivation of TRPML1.
The rise in cytosolic Ca2+ under ML-SA1 conditions originated
at the lysosome and via TRPML1 because cytosolic Ca2+ in con-
trol andMLIV human fibroblasts pretreated with GPN did not rise
after additional treatment with ML-SA1 (Figure 1J).
Collectively, these data indicate that the presence of an
elevated Ca2+ leak out of PS1KO lysosomes is mediated by
TRPML1, which is hyperactivated in PS1KO cells due to elevated
lysosomal pH.
Restoring Normal Lysosomal pH, but Not Lysosomal
Ca2+ Homeostasis Alone, Rescues Lysosomal Deficits
and Autophagy
Lysosomal Ca2+ dysfunction caused by PS1 deletion was pro-
posed to be responsible for autophagy deficits in PS1KO cells
(Coen et al., 2012), although no evidence or underlying mecha-
nism was shown. Because treatment of PS1KO cells with Ned-
19 normalized TRPML1 activity (Figure 1E) and prevented
abnormal lysosomal Ca2+ efflux, we investigated whether orFigure 1. TRMPL1 Mediates Lysosomal Ca2+ Efflux in PS1KO Cells
(A) Lysosomal Ca2+ is reduced (WT, n = 336; PS1KO, n = 338), and cytosolic Ca
(B) Cells were treatedwith 5 mM ionomycin followed byGPN (300 mM) tomeasure l
treated for 24 hr with 2 mg/ml U18666a (n = 33) release less lysosomal Ca2+.
(C) Compared toWT (n = 67), PS1KO cells (n = 93) releasedminimal Ca2+ after 1 mM
significantly lowered in WT cells treated with U18666a (n = 25).
(D) Addition of 5 mM NH4Cl increased cytosolic Ca
2+ in PS1KO (n = 64) but not
(E) Twenty mMML-SA1 (black arrowhead) elevated cytosolic Ca2+ levels in PS1KO
19 (0.5 mM, 24 hr, n = 167) (gray arrowheads indicate ionomycin addition).
(F) Seventy-two hr shRNA TPC2KD had no discernible effect on lysosomal or c
lysosomal and cytosolic Ca2+ levels even when TPC2 was knocked down.
(G) Seventy-two hr knockdown of TRPML1 significantly elevated lysosomal Ca2+
(H) Anti-TRMPL1 antibody (16 hr, 5 mg/ml) inhibited ML-SA1-mediated lysosoma
(I) Lysosomal Ca2+ levels determined using GPN are almost normalized in PS1KO
(n = 100).
(J) ConA followed by ML-SA1 induced a rise in cytosolic Ca2+ in WT (n = 33) bu
lysosomes with GPN prior to ML-SA1 abolished Ca2+ release in WT (n = 11) and
Cell Renot reducing this Ca2+ leak influences lysosomal pH or lyso-
some-related function. Although Ned-19 treatment of PS1KO
cells restored normal lysosomal and cytosolic Ca2+ levels (Fig-
ure 2A), its addition to PS1KO cells had no ameliorative effects
on lysosomal pH (Figure 2B), levels of LC3-II (Figure 2C), or
CatD activation in lysosomes measured using Bodipy FL-pep-
statin A (Figure 2D).
Cells were transiently transfected with the eGFP-mRFP-LC3
construct and treated with Ned-19 to assess any alterations
in autophagic flux. Compared with WT controls, untreated
PS1KO cells display a lower percentage of red puncta and an
elevated percentage of yellow puncta, indicating defectivematu-
ration of autophagosomes into acidic lysosomes. Ned-19 did not
affect these percentages, indicating that lysosomal Ca2+ resto-
ration did not restore lysosomal acidity or autophagic flux (Fig-
ure 2E). EM morphometry confirmed these results by showing
that Ned-19 did not alter the abnormally lowered ratio of lyso-
somes to late AVs in PS1KO cells (Figure S2A). Previously, we
demonstrated that autophagy induction was not altered in
PS1KO cells and that reduced autophagic flux was due specif-
ically to delayed lysosomal degradation (Lee et al., 2010). Estab-
lishing that Ned-19 does not influence autophagy induction, we
observed that Ned-19 treatment does not alter levels of either
p-mTOR or p-P70S6K in PS1KO cells (Figure S2B). Thus, the
key driver of autophagic dysfunction in PS1KO cells, namely
markedly delayed degradation, is not due to Ca2+ dysfunction,
as previously speculated (Coen et al., 2012).
Contrastingwith theminimal effect of lysosomalCa2+correction
on autophagy, reversal of lysosomal pH deficits in PS1KO cells
rapidly normalized autophagy and lysosomal function, including
Ca2+ efflux.Wewere able to lower intraluminal lysosomal pHusing
a poly (DL-lactide-co-glycolide) (PLGA) acidic nanoparticle, which
is internalized in cells by endocytosis and targeted to lysosomes
where protons are released in the lysosomal lumen through hydro-
lysis of poly-lactic acid (Baltazar et al., 2012).We identified a nano-
particle species, designated NP-1, as having optimal uptake effi-
ciency and ability to restore lysosomal pH as previously shown in
ARPE-19 cells (Baltazar et al., 2012). Exposure of PS1KO cells to
NP-1 normalized lysosomal pH, lowering it from 5.7 to 4.6 (Fig-
ure 2F). Pretreatment with NP-1 for 24 hr normalized TRPML1 ac-
tivity, as no rise in cytosolic Ca2+ was elicited with ML-SA12+ is elevated in PS1KO cells (WT, n = 148; PS1KO, n = 150).
ysosomal Ca2+ levels. Less Ca2+ is released from PS1KO (n = 18) cells. WT cells
thapsigargin followed by NAADP-AM (100 nM) (arrowhead). Ca2+ release was
WT cells (n = 125).
(n = 151) but not WT cells (n = 206), and this elevation was diminished by Ned-
ytosolic Ca2+ levels in PS1KO cells (n > 90); 0.5 mM Ned-19 (24 hr) restored
and decreased cytosolic Ca2+ in PS1KO cells.
l Ca2+ release in PS1KO cells (n = 60).
cells after 10 mM YM201636 for 1 hr via reduced Ca2+ flux through TRPML1
t not MLIV fibroblasts (n = 29) imaged in a Ca2+-free buffer. Osmotic lysis of
MLIV cells (n = 17). ***p < 0.0001. Error bars are ± SEM.
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Figure 2. Restoring Normal Lysosomal pH, but Not Lysosomal Ca2+ Homeostasis Alone, Rescues Lysosomal Deficits and Autophagy
(A) Ned-19 (0.5 mM, 24 hr) elevated lysosomal Ca2+ (WT n = 453; PS1KO n = 461; PS1KO/Ned-19 n = 522) and decreased cytosolic Ca2+ levels in PS1KO cells (WT
n = 148; PS1KO n = 150; PS1KO/Ned-19 n = 150).
(B) Ned-19 does not alter lysosomal pH in WT or PS1KO cells (n = 9 each).
(C and D) Ned-19 does not reduce elevated LC3-II levels in PS1KO cells (C) (n = 11) or increase in situ CatD activity (D) (n = 3). Scale bars represent 20 mm.
(legend continued on next page)
1434 Cell Reports 12, 1430–1444, September 1, 2015 ª2015 The Authors
(Figure 2G), similar to the lack of effect ofML-SA1onWTcells (Fig-
ure 1E). Thenormalizationof lysosomalCa2+anddecrease incyto-
solicCa2+ levels support the hypothesis that lysosomalCa2+ levels
are dependent on lysosomal acidification (Figure 2H). In addition,
weobserved that lysosomal pHcorrectionwithNP-1 fully restored
CatB and CatD activities in PS1KO lysosomes in situ measured
with MR-CatB and Bodipy-pepstatin A, respectively (Figures 2I
and S2C), as well as levels of mature CatD. Accumulation of the
autophagy substrates, p62 and LC3-II, were also markedly
decreased (Figure2K).Moreover,NP-1decreased thepercentage
of yelloweGFF-mRFP-LC3puncta by 50%and increased the per-
centage of red puncta by30% inPS1KOcells, reflecting a resto-
ration of autophagic flux at the lysosomal clearance stage of auto-
phagy (Figure2J)given thatautophagy inductionmarkersp-mTOR
andp-p70S6Kwere unaltered byNP-1 (Figure S2D). Furthermore,
V0a1 glycosylation was unchanged by NP-1, indicating that reac-
idificationwasdue toprotein release from thenanoparticle andnot
to amelioration of vATPase deficits (Figure S2E).
Elevated Lysosomal Ca2+ Efflux in PS1KO Cells Is
Secondary to Defective Lysosomal Acidification and
Can Be Induced in WT Cells by vATPase Inhibition
Treatment ofWT cells with the vATPase inhibitor, ConA, elevated
lysosomal pH to a level similar to that in untreated PS1KO cells
(Figure 3A) and did not further elevate lysosomal pH in PS1KO
cells (Figure 3A). These results are consistent with previous evi-
dence that, despite a high level of vATPase inhibition, cells can
still achieve a moderate degree of lysosomal acidification (Mind-
ell, 2012). Supporting the close relationship between pH and
Ca2+ content in lysosomes, ConA decreased lysosomal Ca2+
and elevated cytosolic Ca2+ in WT cells (Figure 3B) but, as ex-
pected, did not alter the already abnormal levels of lysosomal
and cytosolic Ca2+ in PS1KO cells where vATPase function is
substantially compromised (Figure 3B). Importantly, ConA inhibi-
tion of vATPase activity in WT cells reproduced previously re-
ported PS1KO lysosome and autophagy deficits, including
elevated LC3-II levels (Figure 3C), lowered CatD activity (Fig-
ure 3D), lowered CatB activity (Figure 3E), increased late AV
accumulation, and decreased lysosome number (Figure 3F)
and autophagic flux measured using the tandem EGFP-mRFP
LC3 reporter (Figure 3G). Moreover, ConA treatment had no ef-
fect on autophagic induction, as both p-mTOR and p-p70S6K
levels remained unchanged (Figure S2F).
PS1 Deletion Leads to Loss of Lysosomal vATPase
Activity
We previously reported reduced V0a1 subunit maturation and
levels in PS1KO cells (Lee et al., 2010; Wolfe et al., 2013). To(E) PS1KO andWT cells transiently transfected for 48 hr with EGFP-mRFP LC3 sh
24 hr.
(F and G) Uptake of lysosome-targeted NP-1 acidic nanoparticles (24 hr, 1 mg/m
ML-SA1 to elevate cytosolic Ca2+ (G) (WT, n = 180; PS1KO, n = 186; PS1KO/NP
(H) NP-1 also elevated lysosomal Ca2+ levels (WT, n = 318; PS1KO, n = 305; PS
PS1KO, n = 150; PS1KO/NP1, n = 150).
(I and J) NP-1 normalized levels of Cat D activity (I), NP-1 reduced yellow puncta (J)
Scale bars represent 10 mM. *p < 0.05, ***/### p < 0.0001.
(K) NP-1 increased mature CatD levels and reduced elevated LC3-II/p62 levels i
Cell Reinvestigate this issue further specifically in lysosomes, we used
a superparamagnetic chromatography isolation procedure
(Walker and Lloyd-Evans, 2015) to isolate highly enriched lyso-
somal preparations from PS1KO and WT cells, comprising 3%
of the total cell lysate (protein: protein) and representing an
enrichment of the LAMP2 lysosomal marker. Western blot anal-
ysis of enriched lysosomes confirmed the purity of lysosome
fractions by demonstrating the presence of minimal calnexin
and EEA1 and strong enrichment of LC3-II and CatD (Figure 4A).
The mature active form of CatD was diminished in PS1KO lyso-
somes, as previously seen in intact cells (Lee et al., 2010). The
V0a1 subunit in purified lysosomes from PS1KO cells was pre-
sent at markedly lowered levels compared to those in WT lyso-
somes and existed predominantly at a lower apparent molecular
weight in PS1KO lysosomes, consistent with it being incom-
pletely glycosylated, as previously reported (Lee et al., 2010).
The ratio of V0a1 relative to LAMP2 used as a lysosome loading
control was lowered 70% in PS1KO lysosomes (Figure 4B). We
next analyzed the assembly of the vATPase complex on isolated
lysosomes by measuring levels of lysosomal V1E1 subunit,
which actively assembles with the membrane bound V0 sub-
complex during formation of the complete vATPase. V1E1 on
PS1KO lysosomes was reduced to similar levels as V0a1 (Fig-
ure 4B), substantiating earlier findings on crude membrane frac-
tions from PS1KO cells (Lee et al., 2010).
To assess activity of the assembled vATPase in purified lyso-
somes, we next measured the ATP-hydrolytic activity of the
complex and its proton pumping capacity directly. The ATP
hydrolysis rate, monitored by release of inorganic phosphate
(Ramirez-Montealegre and Pearce, 2005), was 40% lower in
lysosomes isolated from PS1KO cells relative to WT lysosomes,
while ConA treatment of WT cells reduced ATP hydrolysis by
90%, indicating that, despite the marked loss of V0a1, there
is some residual ATPase activity in PS1KO (Figure 4C). Next,
we measured the rate of proton translocation into the lysosomal
lumen using the quenching of 9-amino-6-chloro-2-methoxyacri-
dine (ACMA), which was 50% lower in PS1KO lysosomes than
in WT lysosomes. As expected, pretreatment of lysosomes with
ConA significantly inhibited proton translocation in WT cells, but
minimally reduced this rate in PS1KO lysosomes, confirming that
loss of PS1 markedly impairs vATPase function (Figure 4D).
The vATPase V0a1 Subunit Is Essential for Lysosomal
Acidification and Autophagic Function
PS1 siRNA treatment of WT cells for 48 hr only partially
decreased expression of mature V0a1 and 96 hr of PS1 siRNA
was needed to decrease V0a1 levels more than 85% (Figure 5A)
and significantly increase LC3-II levels (Figures 5B and 5C),owed no change in percentages of yellow or red puncta after 0.5 mMNed-19 for
l) in PS1KO cells restored normal lysosomal pH (F) (n = 6) and lowered ability of
1, n = 237).
1KO/NP1, n = 313) and lowered cytosolic Ca2+ in PS1KO cells (WT, n = 148;
, and increased red puncta, in PS1KOcells, indicating restored autophagic flux.
n PS1KO cells. Error bars represent ± SEM.
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Figure 3. Inhibition of VATPase Function Induces a PS1KO-like Defective Autophagy Phenotype
(A) ConA (50 nM, 24 hr) elevated lysosomal pH in WT (n = 6 each), but had no effect on PS1KO cells.
(B) ConA decreased lysosomal Ca2+ (WT, n = 155; WT/ConA, n = 153) and elevated cytosolic Ca2+ (WT, n = 154; WT/ConA, n = 152) in WT but had no significant
effect on Ca2+ levels in PS1KO cells (PS1, n = 153 and 164; PS1/ConA, n = 161 and 151, lyso. and cyto.).
(C–F) Con A elevated LC3-II levels (C), decreased in vivo and in vitro CatD enzyme activities and CatB activity (D and E, respectively), and increased late AV
accumulation while decreasing lysosome number (F) (n = 25).
(G) ConA (50 nM) elevated yellow puncta andmarkedly decreased red puncta in EGFP-mRFP-LC3 cells. Scale bars represent 10 mm. *p < 0.05, ***/### p < 0.0001.
Error bars represent ± SEM.indicating diminished lysosomal clearance. LysoTracker signal
decreased 50% after 96 hr of V0a1 siRNA (Figure 5D) but
only 20% after 48 hr, again underscoring the slow turnover
of preexisting V0a1. Similarly, in situ CatB enzyme activity
decreased 60% only after 96 hr of V0a1 siRNA exposure (Fig-
ure 5E). Thus, even after 4 days of siRNA exposure, residual
V0a1 on lysosomes is enough to maintain a minor fraction of
normal proton pumping activity. These results support the idea
that V0a1 is essential for lysosomal acidification and function
and that its turnover is quite long, consistent with previous find-
ings (http://helixweb.nih.gov/ESBL/Database).
Glycosylation of V0a1 Is Critical for Its Stability and
Functions
Glycosylation of the V0a1 subunit has been proposed to influ-
ence its stability and function (Gillespie et al., 1991; Lee et al.,
2010). It was recently demonstrated that glycosylation of residue
R444 in V0a3, an osteoclast-specific V0a isoform, is required for
its proper delivery to lysosomes (Bhargava et al., 2012). To inves-
tigate the role of glycosylation on the V0a1 subunit, we gener-
ated an R447L mutant analogous to the R444L mutation in1436 Cell Reports 12, 1430–1444, September 1, 2015 ª2015 The AuV0a3, using a C-terminal FLAG-tagged V0a1 (V0a1-FLAG) that
enabled the mutant to be differentiated from endogenous V0a1
subunit in murine neuroblastoma (N2a) cells.
To investigate the R447L effects on V0a1 maturation, we
treated lysates stably expressing V0a1-FLAG with PNGase F.
PNGase converted the mature V0a1WT-FLAG to its 100 kDa
immature form, whereas there was no discernible shift in the
mobility of V0a1R447L after PNGase F treatment. Moreover, levels
of V0a1R447L in the stably transfected cells were markedly lower
than levels of V0a1WT in the corresponding cells (Figure 6A). To
analyze whether this decrease was due to rapid degradation of
the unglycosylated protein, cells were treated for 24 hr with the
proteasome inhibitor MG-132, and lysates were immunoblotted
with anti-FLAG antibody. As predicted, the proteasome inhibitor
significantly delayed V0a1R447L degradation (Figure 6B). To
document premature turnover of V0a1R447L, cells were exposed
to cycloheximide for various times. Immunoblot analysis of these
lysates confirmed that the glycosylation mutant V0a1R447L is
rapidly degraded by the proteasome (Figure 6C). Previous
studies demonstrated that immature V0a1 is not correctly deliv-
ered to the lysosome but rather retained in the ER (Lee et al.,thors
Figure 4. PS1KO Lysosomes Are Markedly
Deficient in vATPase V0al Subunit and vAT-
Pase Activity
(A–D) In highly enriched lysosomes from PS1KO
cells (A), V0al subunit levels were decreased (B)
(n = 3), ATP hydrolysis activity was reduced (C),
and proton translocation ability of vATPase was
decreased (D). ConA treatment of WT cells for
24 hr prior to lysosomal enrichment decreased
proton translocation, but had no effect in PS1KO
cells. *p < 0.05, ***p < 0.0001. Error bars represent
SEM.2010). To identify the localization of V0a1R447L, we fractionated
cells on an Opti-prep gradient. Immunoblot analyses of these
fractions revealed that V0a1R447L subunit co-sedimented with
ER-enriched fractions, whereas V0a1WT-FLAG was observed
primarily in lysosome-enriched fractions (Figure 6D). Double-
immunofluorescence analysis using compartmental markers
confirmed the mislocalization of V0a1R447L (Figure 6D).
To further analyze the functional role of V0a1 glycosylation, we
incubated V0a1R447L cells with LysoTracker, Bodipy-FL-pepsta-
tin A, and MR-CatB to assay lysosomal acidification and in situ
activity of CatD and CatB, respectively. Quantitative analyses
demonstrated that both LysoTracker signal and cathepsin activ-
ities were significantly decreased in V0a1R447L cells (Figure 6E),
commensurate with an observed rise in lysosomal pH and
decline in vATPase activity measured directly (Figures 6F and
6G). As expected, levels of autophagy marker protein LC3-II
increased (Figure S3A), and clearance of autophagosomes
was reduced in V0a1R447L cells (Figure 6H), whereas autophagy
induction-related signals (i.e., p-mTOR, p-P70S6K) were not
altered (Figure S3B).
These results are in accord with previous findings and estab-
lish that V0a1 subunit glycosylation is critical for the stability
and lysosomal targeting that enables lysosomal acidification
and hydrolytic function.
PS1 Is an Essential Mediator of Lysosomal Acidification
and Ca2+ Homeostasis in Neurons
To establish that PS1 loss causes a similar lysosomal phenotype
in a neuronal PS1-deficient cell model, we assayed these param-
eters directly in neurons. Importantly, levels of lysosomal Ca2+
were lowered, and cytosolic Ca2+ was elevated significantly
in PS1KO primary neurons (Figure 7A). Western blot analysis
demonstrated that V0a1 maturation is also markedly decreasedCell Reports 12, 1430–1444, Se(Figure 7B). Further indicative of auto-
phagy failure, the numbers of autophagic
vacuoles (AVs), consisting of mainly sin-
gle membrane electron-dense autolyso-
somes and multilamellar organelles,
were significantly increased in neuronal
perikarya (Figure 7C). Consistent with
abnormally elevated lysosomal pH and
disrupted proteolysis, LysoTracker signal
and CatB/D activity were significantly
decreased in PS1KO neurons compared
to WT neurons (Figures 7D–7F), confirm-ing earlier findings in PS1KO cells (Lee et al., 2010). Contrasting
with these current findings, Coen et al. (2012) reported no lyso-
somal acidification deficits in PS1KO neurons. A plausible expla-
nation for their failure to detect differences in neurons lies in the
atypical features of the PS1KO neurons they used. In our PS1KO
neurons, nicastrin maturation is significantly impaired and APP-
CTF levels are increased, as expected from the loss of PS1, and
as reported by other groups (Esselens et al., 2004; Wilson et al.,
2004), while these signature properties of PS1KO were not pre-
sent in the neurons used by Coen et al. (2012).
DISCUSSION
Presenilin 1 plays an important role in Ca2+ homeostasis and
autophagy/lysosomal protein degradation, beyond its well-
studied catalytic role as part of g-secretase (Lee et al., 2010;
Tu et al., 2006). However, the relationship between two major
g-secretase independent functions of PS1, namely mainte-
nance of Ca2+ homeostasis and lysosomal proteolysis, is poorly
understood. Based on an earlier observation that lysosomal
alkalinization increased lysosomal Ca2+ efflux (Christensen
et al., 2002), it was reasonable to suspect that lysosomal acid-
ification failure resulting from loss of PS1 may also disrupt lyso-
somal Ca2+ homeostasis. In this study, we show that acidic
lysosomal pH is indeed essential for maintaining normal lyso-
somal Ca2+ levels, whereas restoration of lysosomal Ca2+ levels
by itself does not significantly affect lysosomal acidification
under these conditions. Our direct measurements reveal sig-
nificantly decreased lysosomal Ca2+ in PS1 ablated cells and
neurons. Additional measurements of lysosomal Ca2+ levels
after GPN-mediated lysosome rupture and Ca2+ release confirm
the lysosomal Ca2+ deficit. Notably, we also demonstrate that
TRPML1-mediated release of lysosomal Ca2+ in PS1KO cellsptember 1, 2015 ª2015 The Authors 1437
Figure 5. vATPase V0a1 Knockdown Inhibits Lysosomal Acidification
(A and B) PS1 siRNA in WT cells decreased V0a1 levels (A) and increased LC3-II (B).
(C–E) Levels of LC3-II were increased after V0a1 subunit siRNA treatment (C). LysoTracker intensity (n = 55) (D) and CatB activity (n = 30) (E) decreased after V0a1
siRNA. Scale bars represents 10 mm. *p < 0.05. Error bars represent SEM.substantially increases cytosolic Ca2+ levels and is a major
contributor to the PS1-related Ca2+ defect previously attributed
only to disruption of ER Ca2+ homeostasis (Chan et al., 2000;
Cheung et al., 2010).
Increasing evidence suggests that the primary Ca2+ stores tar-
geted by NAADP are present in acidic organelles such as the
lysosome and are distinct from pools in the ER (Calcraft et al.,
2009). TPC2 is the primary NAADP-dependent Ca2+ efflux chan-
nel in the lysosome, and its activation via NAADP has previously
been shown to be sensitive to lysosomal pH. In fully acidified
lysosomes, Ca2+ stores that are lowered by elevated NAADP
levels become replenished when the dissociation rate between
NAADP and TPC2 increases (Pitt et al., 2010). When lysosomal
pH is normal, elevated cytosolic NAADP levels induce lysosomal
Ca2+ release from lysosomal stores (Churchill et al., 2002; Lloyd-
Evans et al., 2008). However, increasing lysosomal pH leads to a
failure of the purified TPC2 to dissociate from NAADP, rendering
the channel inactive (Pitt et al., 2010).
PS1KO cells, which have elevated lysosomal pH, treated with
NAADP-AM did not release lysosomal Ca2+, whereas U1866a-
treated WT cells, possessing a normal lysosomal pH, released
lysosomal Ca2+ in response to NAADP-AM treatment (Lloyd-
Evans et al., 2008). These data are consistent with the TPC2
channel being inactive in PS1KO cells. Conversely, ML-SA1,
an agonist for the lysosomal TRPML1 channel, evoked a stron-
ger release of Ca2+ in PS1KO cells than in WT cells, despite
the lower lysosomal Ca2+ content in PS1KO cells.1438 Cell Reports 12, 1430–1444, September 1, 2015 ª2015 The AuOur data indicate that TRPML1 in PS1KO cells is more respon-
sive to low concentrations of the agonist, ML-SA1, and likely ex-
ists in a hyperactive state. In addition, there have been reports
that endogenous TRPML1, as opposed to a constitutively active
mutant form of TRPML1 overexpressed in cells (Dong et al.,
2009), is less active at a lower pH range and becomes more
active as pH increases (Raychowdhury et al., 2004). This prop-
erty of the channel appears to contribute to its hyperactivity
at elevated lysosomal pH in PS1KO cells. To establish that
TRPML1, the lysosomally localized member of the TRPML fam-
ily, is the primary Ca2+ efflux channel and is specifically activated
by elevated lysosomal pH, we showed that TRPML1 knockdown
in PS1KO cells elevates lysosomal Ca2+ and decreases cytosolic
Ca2+ and that an inhibitory antibody against TRPML1 abolishes
ML-SA1-mediated lysosomal Ca2+ release. In addition, cytosolic
Ca2+ did not rise when ML-SA1-treated control and MLIV fibro-
blasts were pretreated with GPN to abolish any Ca2+ signal
from lysosomal stores, implying a principal lysosomal source
for this cytosolic Ca2+ rise. Moreover, we observed a large
increase in cytosolic Ca2+ in ConA-treated control fibroblasts,
indicating that inhibition of vATPase and thus an elevation of
lysosomal pH can induce TRPML1 sensitivity to ML-SA1. Addi-
tionally, pretreatment of PS1KO cells with NP-1 to lower lyso-
somal pH normalized the rise in cytosolic Ca2+ mediated by
ML-SA1 as observed in untreated cells.
Ned-19 normalized the abnormal ML-SA1-induced Ca2+
release in the PS1KO cells, providing additional evidence thatthors
the increased Ca2+ efflux is due to hyperactive TRPML1. By
blocking lysosomal Ca2+ leak, Ned-19 restored Ca2+ homeosta-
sis in PS1KO cells, but had no detectable effect on lysosomal pH
or any aspect of the abnormal lysosomal/autophagy phenotype
in PS1KO cells. If lysosomal Ca2+ fluxes were a significant influ-
ence on lysosomal acidification, we would have expected Ned-
19 treatment to alter the elevated lysosomal pH in PS1KO cells.
In addition, ConA recapitulated PS1KO phenotypes in WT cells
but, as expected, did not worsen the Ca2+ defect in PS1KO cells.
Thus, our data provide strong evidence that elevated lysosomal
pH is the basis for both reduced lysosomal Ca2+ and lysosomal/
autophagy defects in PS1KO cells.
In AD, ER Ca2+ homeostasis is dysregulated andmultiple Ca2+
regulatory mechanisms, including inositol 1,4,5-triphosphate
and ryanodine receptors, are known to be disrupted by PS1
loss of function in early onset AD (Chan et al., 2000; Cheung
et al., 2010), leading to an increase in cytosolic Ca2+. Interest-
ingly, lysosomal Ca2+ release can trigger secondary ER Ca2+
release via nanojunctions (Fameli et al., 2014; Kilpatrick et al.,
2013). Possible crosstalk between ER and lysosomal Ca2+
fluxes, however, has not been fully considered in AD pathogen-
esis. Our current data raise the possibility that lysosomal Ca2+
release or leak driven by lysosomal acidification deficits could
promote ER Ca2+ dysregulation, in addition to directly elevating
cytosolic Ca2+ levels. The findings show a role of both pH and
lysosomal Ca2+ leak in maintaining normal lysosomal Ca2+ levels
and a capability of lysosomal Ca2+ leak to alter cytosolic Ca2+
levels substantially.
Lysosomal acidification is maintained primarily by the vAT-
Pase, a protein complex composed of a membrane-bound V0
domain and a peripherally associated V1 domain. The largest
subunit of the V0 sub-complex, V0a, is an integral membrane
protein with four known isoforms (a1–a4), a1 being the major
one in brain (Nishi and Forgac, 2000). We demonstrated previ-
ously that PS1 deletion, PS1/2 deletion, or FAD-related mutation
of PS1 reduces vATPase immunoreactivity on lysosomes, ele-
vates lysosomal pH, depresses lysosomal protease activation,
and significantly delays autophagic protein turnover. Moreover,
stable transfection of PS1 into PS1/2 DKO cells reverses these
features and restores V0a1 subunit glycosylation, lysosomal
acidification, and autophagic clearance (Lee et al., 2010). Im-
portantly, additional studies have also demonstrated impaired
vATPase V0a1 subunit maturation and endolysosomal acidifica-
tion in multiple models, including PS1 ablated cells or mutant
PS1 models (Avrahami et al., 2013; Coffey et al., 2014; Dobro-
wolski et al., 2012; Torres et al., 2012; Wolfe et al., 2013), under-
scoring that the acidification defect induced by PS1 loss of
function is generalizable across various cell types. In one study,
PS1 and vATPase V0a1 subunit were reported to have no role in
lysosomal pH regulation (Coen et al., 2012), and differences be-
tween methods and cell culture conditions might explain some
discrepancies between this study and studies by us and others.
In our current study, we show that lysosomes purified from
PS1KO cells contained markedly lowered levels of V0a1 subunit,
which was associated with impaired vATPase assembly on lyso-
somes and commensurate reductions of lysosomal proton
pumping activity. Using siRNA gene knockdown, we further
demonstrated that lysosomal acidification and lysosomalCell Reenzyme activation require the vATPase V0a1 subunit, in agree-
ment with other findings that V0a1 subunit is critical for vesicular
acidification (Raines et al., 2013; Saw et al., 2011). Notably, V0a1
has a long half-life on lysosomes, requiring substantial duration
of siRNA exposure (96 hr) to lower lysosomal levels of the subunit
sufficiently to alter acidification, which is 48 hr longer than the
interval used in the Coen et al. (2012) study where a pH change
could not be detected upon siRNA treatment. We observed that
the glycosylation mutant V0a1R447L stably expressed in cells ex-
hibited increased ER retention, decreased stability promoting
loss via ERAD, and deficient lysosomal targeting and assembly.
Without proper maturation of the V0a1 glycosylation mutant,
lysosomal acidification and functions, including lysosomal
enzyme activation and autophagic cargo degradation, were
impaired. These findings strongly support the conclusion that
both the expression and proper glycosylation of V0a1 are critical
for its lysosomal function.
Our data also establish that defective lysosomal acidification
is the essential factor accounting for the abnormal autophagy/
lysosomal degradation and lysosomal Ca2+ phenotypes in PS1
deficient neurons and non-neural cells. ConA inhibition of the
vATPase in WT cells reproduced all of the features of the
PS1KO phenotype, whereas Ned-19 corrected lysosomal Ca2+
levels without influencing lysosomal pH deficits or other aspects
of autophagy dysfunction. Most importantly, we were able to
reverse both autophagy and lysosomal Ca2+ deficits specifically
by re-acidifying lysosomes using a form of lysosome-targeted
acidic nanoparticles previously shown to restore lysosomal pH
in ARPE 19 cells, a model of macular degeneration (Baltazar
et al., 2012).
In conclusion, we have shown that the vATPase V0a1 subunit
is essential for lysosomal acidification and that its maturation
and proper functional assembly on lysosomes require PS1.
Moreover, we have established that lysosomal Ca2+ homeosta-
sis is modulated by lysosomal pH and that the abnormal
TRPML1 mediated efflux of Ca2+ from lysosomes induced by
PS1 deletion is a secondary consequence of impaired lysosomal
acidification caused by inadequate levels of vATPase activity.
Substantial evidence suggests that both the lysosomal/autopha-
gic and calcium homeostasis abnormalities induced by PS1 loss
of function are likely to contribute significantly to disease patho-
genesis in this familial form of AD, as well as in late-onset AD
where similar pathobiology develops possibly via different
initiating factors (Nixon and Yang, 2011). Restoration of auto-
phagy/lysosomal function in PS1-deficient cells by reacidifying
lysosomes suggests innovative approaches to therapy for AD
and other neuropathological conditions associated with lyso-
somal pH elevation.
EXPERIMENTAL PROCEDURES
Methods are described in detail in the Supplemental Experimental
Procedures.
Cell Lines and Reagents
Murine blastocysts with different PS1 genotypes (WT, BD6; PS1KO, BD15)
were previously characterized (Lee et al., 2010). Control and MLIV human fi-
broblasts were purchased from Coriell Cell Repository and have numbers
GM005399 and GM002527, respectively, and were maintained in 10% fetalports 12, 1430–1444, September 1, 2015 ª2015 The Authors 1439
Figure 6. The Mutant Protein Construct V0a1R447L-FLAG Is Not Glycosylated and Is Degraded in N2a Cells
(A) Cell lysates were immunoblotted with anti-FLAG antibody followed by PNGase F treatment. Nicastrin blots provided as a positive control for PNGase
treatments.
(B and C) Cell lysates were immunoblotted with anti-FLAG antibody followed by proteasome inhibitor (B) (MG-132) treatment for 24 hr (C). Cell lysates were
immunoblotted with anti-FLAG antibody followed by CHX treatment for the indicated time. Cell lysates form V0a1R447L-FLAGwere preincubated withMG-132 for
24 hr then treated with CHX for the indicated time. Levels of V0a1-FLAG were quantified. Results were plotted as ratios normalized to the non-treated sample for
each cell line.
(legend continued on next page)
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Figure 7. Lysosomal Ca2+, Acidification, and Enzyme Activities Are Reduced in PS1KO Neurons
(A) Lysosomal Ca2+ (WT, n = 180; PS1KO, n = 181) was reduced, and cytosolic Ca2+ (n = 20) was elevated in PS1KO neurons.
(B–F) In PS1KO neurons, maturation of V0a1 and nicastrin was decreased, and APP-CTF levels were increased (B). AVs accumulate in both cell bodies and
axons (C). LysoTracker signal (D) and in vivo CatB (E) and CatD (n = 28) (F) activities were decreased. Scale bars represents 10 mm. ***p < 0.0001. Error bars
represents SEM.bovine serum (FBS) in DMEMwith 5% CO2. Murine neuroblastoma (N2A) cells
were maintained in DMEM with penicillin/streptomycin and 10% FBS at 37C
and 5%CO2.Mouse PS1 (MSS208049) and scramble (12935-200) siRNAwere
purchased from Invitrogen and mouse vATPase V0a1 siRNA (11975) from
Thermo Scientific. Cells were transfected using Lipofectamine RNAiMAX (Invi-
trogen). Primary cortical neuronal culture were derived from E15 stage pups
from PS1 (+/) crosses and cultured with Neurobasal medium. These exper-
iments were performed according to ‘‘Principles of Animal Care’’ (NIH, 1985)
and approved by the Institutional Animal Care and Use Committee at the Na-
than Kline Institute.
A musculus v-ATPase V0a1WT-FLAG construct (EX-Mn20338-M13) was
purchased from GeneCopoeia. A V0a1R447L-FLAG mutant DNA construct
was generated using a QuikChange II XL site-directed mutagenesis kit (Agilent
technologies, #200521) according to manufacturer’s instructions with 50-
GCATGGTGTTCAGCGGCCTATACATTATTCTTCTGATG-30 and 50-CATCAG
AAGAATAATGTATAGGCCGCTGAACACCATGC-30 primer set. After estab-
lishing the stable cell line, cells were maintained with G418 (300 mg/ml)-con-
taining medium.(D) Immunoblot of V0a1-FLAG distribution in subcellular fractions of V0a1WT-FL
localized in fractions 5–11 and lysosomal marker proteins (LAMP-1 and mature C
alization of V0a1-FLAG and LAMP-2 in V0a1WT -FLAG cells, whereas V0a1R447L-F
(E) Cells were incubated with LysoTracker for lysosomal acidification assay. To a
FL-pepstatin A and MR-CatB for CatD and CatB activity, respectively. Scale bar r
MR-CatB, n = 55). Results were plotted as ratios normalized to V0a1WT-FLAG.
(F) Lysosomal pH values were measured ratiometrically using LysoSensor Yellow
(G) v-ATPase activity was reduced in V0a1R447Lcells.
(H) Autophagosomes were immunolabeled with Cyto-ID autophagy detection kit.
Scale bar represents 10 mm. *p < 0.05, **p < 0.001, ***p < 0.0001. Error bars rep
Cell ReEither GFP-shTPCN2 or GFP-shTRPML1 (QIAGEN) were transfected with
Lipofectamine 2000 (Invitrogen) for 72 hr, and calcium measurements for cells
containing theGFPsignalwerecalculated foreither cytosolicor lysosomalCa2+.
Gel Electrophoresis, Immunoblotting, and Confocal Laser Scanning
Microscopy
Experiments were performed as previously described (Lee et al., 2010).
Deglycosylation and Cycloheximide Treatment
To assess FLAG-tagged V0a1 mutant glycosylation, samples were treated for
24 hr at 37Cwith PNGase F using an enzymatic deglycosylation kit according
to the manufacturer’s instruction (PROzyme). To assess the stability of the
V0a1 mutant, samples were treated with CHX (100 mg/ml) for 0, 2, 4, 8, and
24 hr with or without pretreatment with MG-132 (1 mM/ml, 24 hr) and then
analyzed by SDS-PAGE.
Subcellular Fractionation and Enzyme Activity for Cathepsins
Procedures were performed as previously described (Lee et al., 2010).AG and V0a1R447L-FLAG. ER marker proteins (Ribophorin-I and PDI) primary
atD) mainly in fractions 13–17. Double immunostaining showed strong coloc-
LAG strongly colocalized with ERmarker calnexin. Scale bar represents 10 mm.
ccess the in vivo lysosomal enzyme activity, cells were incubated with Bodipy-
epresents 10 mm. Intensity of signal was quantified (LT, n = 60; Bodipy, n = 50;
/Blue-dextran (n = 10, at least 6 3 103 cells/n).
Results were plotted as mean of AV (Cyto-ID) puncta number per cells (n = 80).
resent ± SEM.
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Lysosomal pH Measurement and Ultrastructural Analyses
Procedures were performed as previously described (Wolfe et al., 2013).Lysosomal Isolation
Cells were incubated in growth medium containing 1 mM HEPES (pH 7.2)
and 10% Dextran-conjugated magnetite (Liquid Research LLC) for 24 hr
and then chased in normal growth media for 24 hr. Cells were washed in
PBS then harvested in 4 ml of ice-cold Buffer A. Cells were then homoge-
nized with 40 strokes of a tight-fitting pestle in a Dounce homogenizer
then passed through a 22G needle five times. After homogenization, 500 ml
of ice-cold Buffer B (220 mM HEPES, 375 mM KCL, 22.5 mM MgAc,
1 mM DTT, DNase I) was added and samples were then centrifuged at 750
3 g for 10 min. The supernatant was then decanted over a QuadroMAC LS
column that had previously been equilibrated with 0.5% BSA in PBS. The
pellet was subjected to re-addition of 4 ml cold Buffer A and 500 ml cold
Buffer B and then resuspended and recentrifuged. DNase I (10 ml/ml in
PBS) was added, and the column was then incubated for 10 min and then
washed with 1 ml cold PBS. Lysosomes were eluted by removing the column
from the magnetic assembly, adding 500 ml of PBS and forced through the
column using a plunger.vATPase Activity Assay
Lysosome-enriched fractions were mixed with 3 vol of Buffer and incubated at
37C for 5 min. After incubation, the reaction was started by addition of 2 mM
ATP and incubated 20 min at 37C. The ATPase reaction was stopped after
25 min by the addition of 2 ml of molybdate solution and 0.2 ml of ascorbic
acid and then developed for 5 min at room temperature. Control samples
were measured in the presence of the vATPase inhibitor ConA (1 mM), and
the experimental values were subtracted accordingly. Absorbance was
measured at 750 nm, and solutions of KH2PO4 were used to generate a stan-
dard curve.Proton Translocation Assay
Proton transport activity into the lumen of isolated lysosomes was measured
by fluorescence quenching of ACMA in the presence or absence of 1 mM con-
canamycin A. Lysosomes were added to a cuvette containing 2 ml of reaction
buffer. The reaction was started by the addition of 1 mM ATP in BTP (pH 7.5), a
measurement (ex412/em480) taken every 5 s for 600 s on a SpectraMax M5
multimode reader (Molecular Devices).Lysosomal Ca2+ Measurements
Cells were plated on glass bottom dishes the night before treatment. For base-
line calcium measurements, cells were incubated with 25 mg/ml rhod-dextran
for 12 hr before imaging. For all cytosolic measurements, cells were incubated
with either 5 mM Oregon-Green 488 Bapta-1 AM (Life Technologies) or 2 mM
Fura-2 AM (Life Technologies) for 1 hr and then chased with complete medium
for 30 min. Cells were washed with HBSS (Invitrogen) and imaged and
analyzed using ImageJ (NIH).
Release of lysosomal Ca2+ was measured using methods adapted from
those previously described (Lloyd-Evans et al., 2008). Cells were plated on
m-Slide eight-well imaging dishes (ibidi), left to adhere overnight and then
treated with 2 mg/ml U18666a for 24 hr as appropriate. Postincubation, cells
were loaded with either 5 mM Fluo3-AM or 5 mM Fura 2-AM (StratechScientific
LTD) in DMEM with 1% BSA and 0.0025% Pluronic acid F127 for 1 hr at 37C
and then washed, left for 10 min to allow deesterification of the calcium dye,
and imaged in 13 HBSS with 1 mM HEPES, 1 mM MgCl2, and 1 mM CaCl2.
Ca2+-free HBSS was used for all human fibroblast experiments. Intracellular
Ca2+ responses were recorded using a Zeiss Colibri LED microscope system
with an AxiocamMrm CCD camera and Zeiss Axiovision software version 4.7
with the additional physiology module for live cell Ca2+ imaging.Acidic Nanoparticle Treatment
PLGA ResomerH RG 502 H was purchased from Boerhinger Ingelheim and
prepared as previously described (Baltazar et al., 2012).1442 Cell Reports 12, 1430–1444, September 1, 2015 ª2015 The AuAnalytical Procedures
Quantitative colocalization analysis was performed using ImageJ software
(NIH Image), and all experiments were performed in triplicate unless otherwise
indicated. Error bars represent ± SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.07.050.
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